product pipeline

Santaris Pharma A/S® is developing RNA-targeted therapies for patients across a range of diseases. We use our LNA Drug Platform to rapidly identify and advance antisense drug candidates with exceptional therapeutic properties.

Years of drug discovery and development experience, combined with our strategic industry partnerships, have generated a proprietary pipeline of innovative pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases and infectious diseases.